Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Anti-CGRP monoclonal antibodies: the next era of migraine prevention
When we work with patients on hormone optimization, we dont just focus on testosterone numberswe look at the complete biological picture, including antioxidant status and cellular health
In mouse models of androgenetic alopecia, topical GHK-Cu has produced hair regrowth comparable to or modestly better than 5 percent minoxidil, with faster entry into anagen phase
DSIP is under active research for potential application in: Individuals with insomnia or light, fragmented sleep Those with chronic stress or HPA axis dysfunction Athletes and biohackers seeking enhanced recovery People working night shifts or experiencing circadian misalignment Adults with low growth hormone output or reduced sleep efficiency Patients with PTSD or trauma-related sleep disruption (research ongoing) DSIP is not FDA-approved for any medical condition and should only be used in research settings under supervision
